UBX - Margin resik Unity Biotechnology, Inc

Simbol resmi perusahaan Unity Biotechnology (UBX)

Unity Biotechnology (UBX) sales margins demonstrate the success of a leader in creating senolytic molecules for the therapy of ocular pathologies. Business efficiency is bolstered by the implementation of robotic screening and software-based processing of research data. Furthermore, the development of anti-aging treatments provides access to an exclusive market niche with high pricing power, and the value of 0.00 corresponds to the current metric of this indicator.

Margin resik Unity Biotechnology (UBX): kanggo periode 04.07.2022 - 19.07.2025

Rincian analitis perusahaan Unity Biotechnology

- rega saham lan prakiraan rega para ahli:
Analisis fundamental perusahaan:Unity Biotechnology, Inc, UBX
Produk asil prodhuksi Unity Biotechnology Inc.

Net profit margin measures the portion of net income in every dollar of revenue, determining the ultimate efficiency of the operating model. This ratio allows investors to filter out volatile assets by assessing a business's ability to generate real income. By analyzing the net profit margin percentage on GURU.Markets, one can identify hidden overvaluation risks. For Unity Biotechnology (UBX), this indicator is critical due to the absence of commercial products. Negative price action here reflects the massive expenditures on clinical trials in the struggle against competitors.

Analisis perusahaan pesaing

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Margin resik boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin dodolan resik|Rentabilitas dodolan resik IMNN (Imunon, Inc.)|Margin dodolan resik PHIO|MBIO - Margin resik|Margin dodolan resik RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin resik|Applied DNA - Margin dodolan resik|Margin resik Bluebird Bio|ImmunoPrecise (IPA) - Margin resik|Margin bathi resik OMGA (Omega)|Margin resik Singular Genomics Systems|Margin resik regulusrx.com RGLS|Margin resik Syros Pharmaceuticals Inc. (SYRS)|Margin dodolan perusahaan Codex DNA|Margin resik TRACON TCON